Ocular Therapeutix Other Long Term Liabilities (Quarterly) Insights

Ocular Therapeutix, Inc. (OCUL)

8.82 +0.41 (+4.88%) USD | NASDAQ | Feb 24, 12:18

View Other Long Term Liabilities (Quarterly) for OCUL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Boston Scientific Corp.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
EyePoint Plc	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade